Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hereditary angioedema and post traumatic stress disorder: a reciprocal relationship?

Orphanet journal of rare diseases·2026
Same author

Arerugi = [Allergy]·2026
Same author

Incriminating the inotrope: Dobutamine, eosinophilia, and myocarditis.

The journal of allergy and clinical immunology. Global·2026
Same author

Fertilization with Protamine-2 deficient sperm triggers abnormal pronucleus development and zygotic cleavage†.

Biology of reproduction·2026
Same author

Body weight distribution of US patients with myasthenia gravis.

Journal of medical economics·2025
Same author

Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study.

Advances in therapy·2025

Related Experiment Video

Updated: May 11, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

Recognizing and managing hereditary angioedema.

Kevin Tse1, Bruce L Zuraw

  • 1Division of Rheumatology, Allergy, and Immunology, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.

Cleveland Clinic Journal of Medicine
|May 3, 2013
PubMed
Summary
This summary is machine-generated.

Hereditary angioedema causes severe swelling attacks without hives. Prompt diagnosis and new treatments are crucial for managing this rare, life-threatening condition and reducing complications.

Related Experiment Videos

Last Updated: May 11, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

Area of Science:

  • Immunology
  • Genetics
  • Vascular Biology

Background:

  • Hereditary angioedema (HAE) is a rare genetic disorder.
  • Characterized by recurrent, unpredictable swelling episodes affecting various body parts, often without urticaria (hives).
  • Can lead to severe morbidity and mortality if not promptly managed.

Purpose of the Study:

  • To highlight the critical need for early diagnosis of hereditary angioedema.
  • To emphasize the importance of timely treatment initiation for HAE patients.
  • To inform about the recent advancements in pharmacotherapy for HAE.

Main Methods:

  • Literature review of HAE pathophysiology and clinical presentation.
  • Analysis of diagnostic criteria and challenges.
  • Overview of current and emerging therapeutic options for HAE management.

Main Results:

  • HAE attacks are triggered by bradykinin pathway dysregulation.
  • Delayed diagnosis contributes to significant patient suffering and healthcare burden.
  • Novel C1 inhibitor therapies and bradykinin receptor antagonists show promise.

Conclusions:

  • Early recognition and diagnosis of hereditary angioedema are paramount.
  • Available treatments can effectively manage acute attacks and prevent future episodes.
  • Ongoing research aims to further improve HAE patient outcomes.